NM_001388492.1:c.7797A>G
Variant names:
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_001388492.1(HTT):c.7797A>G(p.Leu2599Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.302 in 1,613,154 control chromosomes in the GnomAD database, including 76,328 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.27 ( 6303 hom., cov: 33)
Exomes 𝑓: 0.31 ( 70025 hom. )
Consequence
HTT
NM_001388492.1 synonymous
NM_001388492.1 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.93
Publications
33 publications found
Genes affected
HTT (HGNC:4851): (huntingtin) Huntingtin is a disease gene linked to Huntington's disease, a neurodegenerative disorder characterized by loss of striatal neurons. This is thought to be caused by an expanded, unstable trinucleotide repeat in the huntingtin gene, which translates as a polyglutamine repeat in the protein product. A fairly broad range of trinucleotide repeats (9-35) has been identified in normal controls, and repeat numbers in excess of 40 have been described as pathological. The huntingtin locus is large, spanning 180 kb and consisting of 67 exons. The huntingtin gene is widely expressed and is required for normal development. It is expressed as 2 alternatively polyadenylated forms displaying different relative abundance in various fetal and adult tissues. The larger transcript is approximately 13.7 kb and is expressed predominantly in adult and fetal brain whereas the smaller transcript of approximately 10.3 kb is more widely expressed. The genetic defect leading to Huntington's disease may not necessarily eliminate transcription, but may confer a new property on the mRNA or alter the function of the protein. One candidate is the huntingtin-associated protein-1, highly expressed in brain, which has increased affinity for huntingtin protein with expanded polyglutamine repeats. This gene contains an upstream open reading frame in the 5' UTR that inhibits expression of the huntingtin gene product through translational repression. [provided by RefSeq, Jul 2016]
HTT Gene-Disease associations (from GenCC):
- Huntington diseaseInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae), Orphanet
- Lopes-Maciel-Rodan syndromeInheritance: AR Classification: STRONG, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
- juvenile Huntington diseaseInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.59).
BP6
Variant 4-3225692-A-G is Benign according to our data. Variant chr4-3225692-A-G is described in ClinVar as Benign. ClinVar VariationId is 1627136.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.93 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.365 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.272 AC: 41363AN: 151906Hom.: 6297 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
41363
AN:
151906
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.298 AC: 74155AN: 248722 AF XY: 0.292 show subpopulations
GnomAD2 exomes
AF:
AC:
74155
AN:
248722
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.305 AC: 445815AN: 1461130Hom.: 70025 Cov.: 35 AF XY: 0.301 AC XY: 219034AN XY: 726894 show subpopulations
GnomAD4 exome
AF:
AC:
445815
AN:
1461130
Hom.:
Cov.:
35
AF XY:
AC XY:
219034
AN XY:
726894
show subpopulations
African (AFR)
AF:
AC:
5002
AN:
33472
American (AMR)
AF:
AC:
13004
AN:
44660
Ashkenazi Jewish (ASJ)
AF:
AC:
7898
AN:
26116
East Asian (EAS)
AF:
AC:
14591
AN:
39676
South Asian (SAS)
AF:
AC:
16618
AN:
86232
European-Finnish (FIN)
AF:
AC:
23948
AN:
53374
Middle Eastern (MID)
AF:
AC:
792
AN:
5764
European-Non Finnish (NFE)
AF:
AC:
346299
AN:
1111482
Other (OTH)
AF:
AC:
17663
AN:
60354
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.465
Heterozygous variant carriers
0
14707
29415
44122
58830
73537
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
11386
22772
34158
45544
56930
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.272 AC: 41393AN: 152024Hom.: 6303 Cov.: 33 AF XY: 0.274 AC XY: 20385AN XY: 74300 show subpopulations
GnomAD4 genome
AF:
AC:
41393
AN:
152024
Hom.:
Cov.:
33
AF XY:
AC XY:
20385
AN XY:
74300
show subpopulations
African (AFR)
AF:
AC:
6686
AN:
41476
American (AMR)
AF:
AC:
4059
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
AC:
1065
AN:
3464
East Asian (EAS)
AF:
AC:
1945
AN:
5136
South Asian (SAS)
AF:
AC:
942
AN:
4814
European-Finnish (FIN)
AF:
AC:
4896
AN:
10560
Middle Eastern (MID)
AF:
AC:
45
AN:
294
European-Non Finnish (NFE)
AF:
AC:
21035
AN:
67968
Other (OTH)
AF:
AC:
510
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1488
2975
4463
5950
7438
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
434
868
1302
1736
2170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1092
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.